IL6 and neoplasm: In their publication, the authors suggested a mechanism by which CCL2 and IL-6 potentiate tumor progression, as the tumor infiltrating monocytes are protected from apoptosis (see CCL2 Enhances Myeloid Cell Survival and Proliferation) and skewed toward a protumorigenic M2 phenotype (10).